ConductScience.org, home

Paper2024969

Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.

Yoshida S and 3 others. Antimicrob Agents Chemother, 1991. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Papers, record 2024969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2024969

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yoshida SS
2Kojima TT
3Inoue MM
4Mitsuhashi SS

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
FluoroquinolonesMajor topic
NorfloxacinMajor topic
Staphylococcus aureusMajor topic
Carbonyl Cyanide m-Chlorophenyl Hydrazone
Drug Resistance, Microbial
Microbial Sensitivity Tests
Staphylococcal Infections

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16237904Mutational resistance to 4-quinolone antibacterial agents.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6237904PubMed
22393270In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2393270PubMed
33521490Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3521490PubMed
43532944Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3532944PubMed
53026239Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3026239PubMed
63034057Mechanisms of action of and resistance to ciprofloxacin.Am J Med1987https://conductscience.org/library/papers/3034057PubMed
72823695Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2823695PubMed
82829712Norfloxacin resistance in a clinical isolate of Escherichia coli.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2829712PubMed
93056253Endogenous active efflux of norfloxacin in susceptible Escherichia coli.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3056253PubMed
102658782Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2658782PubMed
112502066Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2502066PubMed
122679373
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2679373PubMed
132514623Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2514623PubMed
142558617In vitro activity of AT-4140 against clinical bacterial isolates.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2558617PubMed
153010850Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3010850PubMed

Download CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
17101679Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17101679PubMed
9925528Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/9925528PubMed
9624501Mode of action of sulfanilyl fluoroquinolones.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624501PubMed
9303396Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9303396PubMed
8585727Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8585727PubMed
8549336Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.Drugs1995https://conductscience.org/library/papers/8549336PubMed
7927834Mechanisms of quinolone resistance.Infection1994https://conductscience.org/library/papers/7927834PubMed
7904438Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/7904438PubMed
7689446Mechanisms of resistance to quinolones.Drugs1993https://conductscience.org/library/papers/7689446PubMed
1804005In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1804005PubMed
1667255Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1667255PubMed
1666499Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1666499PubMed
1666495Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1666495PubMed
1503431Active efflux mechanisms for antimicrobial resistance.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1503431PubMed
1416840Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1416840PubMed
1336340Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1336340PubMed
1332589Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1332589PubMed
1323957Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1323957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2024969

GET https://conductscience.org/api/papers/v1/2024969/authors